SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Robb Stephen

(Last)

(First)

(Middle)

1221 BROADWAY

(Street)

OAKLAND

946121888

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/01/2004

3. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP - Fin. Planning & Analysis

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	7,247	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy) - 00AD	04/26/2002	04/26/2010	Common Stock	5,000	$35.78	D
Stock Option (Right to Buy) - 00AN	09/20/2003	09/20/2010	Common Stock	6,429	$36.13	D
Stock Option (Right to Buy) - 01AK	09/24/2004	09/24/2011	Common Stock	7,740	$35.22	D
Stock Option (Right to Buy) - 02AT	10/01/2005⁽¹⁾	10/01/2012	Common Stock	5,055	$40.18	D
Stock Option (Right to Buy) - 03BE	09/17/2007⁽¹⁾	09/17/2013	Common Stock	5,720	$45.25	D
Stock Option (Right to Buy) - 04CQ	09/15/2008⁽¹⁾	09/07/2014	Common Stock	11,000	$53.88	D
Stock Option (Right to Buy) - 99N/2	06/30/2006	12/31/2006	Common Stock	7,800	$67.38	D

Explanation of Responses:

1. Option exercisable in 4 equal installments - 1/4 on each of first, second, third and fourth anniversaries of the grant date.

Remarks:

	By: By Patrick M. Meehan, Assoc. General Counsel for	10/08/2004
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.